rs8847

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_020897.3(HCN3):​c.*1069C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.352 in 152,134 control chromosomes in the GnomAD database, including 10,493 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.35 ( 10479 hom., cov: 31)
Exomes 𝑓: 0.29 ( 14 hom. )

Consequence

HCN3
NM_020897.3 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.536

Publications

14 publications found
Variant links:
Genes affected
HCN3 (HGNC:19183): (hyperpolarization activated cyclic nucleotide gated potassium channel 3) This gene encodes a multi-pass membrane protein that functions as a voltage gated cation channel. The encoded protein is a member of a family of closely related cyclic adenosine monophosphate-binding channel proteins. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012]
PKLR (HGNC:9020): (pyruvate kinase L/R) The protein encoded by this gene is a pyruvate kinase that catalyzes the transphosphorylation of phohsphoenolpyruvate into pyruvate and ATP, which is the rate-limiting step of glycolysis. Defects in this enzyme, due to gene mutations or genetic variations, are the common cause of chronic hereditary nonspherocytic hemolytic anemia (CNSHA or HNSHA). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
PKLR Gene-Disease associations (from GenCC):
  • pyruvate kinase deficiency of red cells
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Orphanet
  • pyruvate kinase hyperactivity
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.683 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HCN3NM_020897.3 linkc.*1069C>T 3_prime_UTR_variant Exon 8 of 8 ENST00000368358.4 NP_065948.1 Q9P1Z3
PKLRNM_000298.6 linkc.*1040G>A 3_prime_UTR_variant Exon 11 of 11 ENST00000342741.6 NP_000289.1 P30613-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HCN3ENST00000368358.4 linkc.*1069C>T 3_prime_UTR_variant Exon 8 of 8 1 NM_020897.3 ENSP00000357342.3 Q9P1Z3
PKLRENST00000342741.6 linkc.*1040G>A 3_prime_UTR_variant Exon 11 of 11 1 NM_000298.6 ENSP00000339933.4 P30613-1
HCN3ENST00000496230.5 linkn.2930C>T non_coding_transcript_exon_variant Exon 8 of 8 2
HCN3ENST00000492035.1 linkn.*14C>T downstream_gene_variant 2

Frequencies

GnomAD3 genomes
AF:
0.351
AC:
53331
AN:
151782
Hom.:
10444
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.491
Gnomad AMI
AF:
0.110
Gnomad AMR
AF:
0.332
Gnomad ASJ
AF:
0.211
Gnomad EAS
AF:
0.703
Gnomad SAS
AF:
0.341
Gnomad FIN
AF:
0.318
Gnomad MID
AF:
0.226
Gnomad NFE
AF:
0.262
Gnomad OTH
AF:
0.334
GnomAD4 exome
AF:
0.286
AC:
67
AN:
234
Hom.:
14
Cov.:
0
AF XY:
0.316
AC XY:
50
AN XY:
158
show subpopulations
African (AFR)
AF:
0.333
AC:
2
AN:
6
American (AMR)
AF:
0.500
AC:
1
AN:
2
Ashkenazi Jewish (ASJ)
AF:
0.500
AC:
1
AN:
2
East Asian (EAS)
AF:
0.262
AC:
22
AN:
84
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4
European-Finnish (FIN)
AF:
0.273
AC:
6
AN:
22
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.250
AC:
24
AN:
96
Other (OTH)
AF:
0.611
AC:
11
AN:
18
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.531
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.352
AC:
53417
AN:
151900
Hom.:
10479
Cov.:
31
AF XY:
0.354
AC XY:
26289
AN XY:
74224
show subpopulations
African (AFR)
AF:
0.491
AC:
20341
AN:
41386
American (AMR)
AF:
0.334
AC:
5103
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.211
AC:
732
AN:
3470
East Asian (EAS)
AF:
0.702
AC:
3609
AN:
5142
South Asian (SAS)
AF:
0.340
AC:
1636
AN:
4806
European-Finnish (FIN)
AF:
0.318
AC:
3352
AN:
10538
Middle Eastern (MID)
AF:
0.233
AC:
68
AN:
292
European-Non Finnish (NFE)
AF:
0.262
AC:
17780
AN:
67964
Other (OTH)
AF:
0.330
AC:
696
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1667
3334
5000
6667
8334
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
514
1028
1542
2056
2570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.291
Hom.:
2454
Bravo
AF:
0.364
Asia WGS
AF:
0.540
AC:
1878
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Pyruvate kinase deficiency of red cells Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.91
DANN
Benign
0.50
PhyloP100
-0.54
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8847; hg19: chr1-155259323; API